The U.S. Securities and Exchange Commission will review a dispute between Express Scripts Holding Co. and New York State's comptroller over the effort to force the prescription-benefits manager to increase cyber-risk disclosures.
DebugScreen: mobile
{
"author": {
"name": "Anders Melin Robert Langreth",
"webUrl": "/author/profile/anders-melin-robert-langreth/",
"description": "",
"imageLarge": "https://secure.gravatar.com/avatar/f16d6fc2845f417ea0e93a3f2b6cd37d?s=136&d=mm&r=g",
"estimate": 1,
"social": [],
"articles": [
{
"uri": "/2018/01/24/express-scripts-clashes-with-investor-over-cyber-r/",
"title": "Express Scripts clashes with investor over cyber-risk disclosure",
"byline": " Anders Melin, Robert Langreth ",
"kicker": "",
"prettyDate": "January 24, 2018",
"timeToRead": "3 minute",
"image": {
"uri": "",
"width": "",
"height": ""
},
"authors": [
{
"webUrl": "/author/profile/anders-melin-robert-langreth/",
"name": "Anders Melin, Robert Langreth"
}
],
"kickerNode": [],
"summary": "The U.S. Securities and Exchange Commission will review a dispute between Express Scripts Holding Co. and New York State's comptroller over the effort to force the prescription-benefits manager to increase cyber-risk disclosures.",
"body": null
}
]
}
}